Hyemi Nam
Overview
Explore the profile of Hyemi Nam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeong B, Nam H, Lee J, Park H, Cho K, Sheen J, et al.
MAbs
. 2022 Jan;
14(1):2013750.
PMID: 35090381
TIGIT is an immune checkpoint receptor that is expressed on subsets of activated T cells and natural killer (NK) cells. Several ligands for TIGIT, including poliovirus receptor (PVR), are expressed...
2.
Lee S, Jang S, Kang J, Park S, Han Y, Nam H, et al.
Front Immunol
. 2021 Dec;
12:778829.
PMID: 34868052
Since the coronavirus disease outbreak in 2019, several antibody therapeutics have been developed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Antibody therapeutics are effective in neutralizing the...
3.
Nam S, Jeong J, Che X, Lim K, Nam H, Park J, et al.
Bone
. 2011 Nov;
50(1):149-55.
PMID: 22036912
We investigated the therapeutic effect of topical Risedronate (RIS) on a mouse model of estrogen-deficient osteoporosis. Fourteen-week-old female mice were ovariectomized and assigned to 4 groups: SHAM-operated (SHAM), OVX mice...
4.
Nam S, Xu Y, Nam H, Jin G, Jeong Y, An S, et al.
Int J Pharm
. 2011 Aug;
419(1-2):114-20.
PMID: 21807082
Ion-paired solutions of risedronate (RIS) with L-arginine (ARG), L-lysine (LYS), and diethylenetriamine (DETA) were tested in vitro for their potential to enhance the penetration of RIS across the skin of...